Medicare Enrolled

Dr. James Valice, M.D.

Ophthalmology · Fraser, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
33080 UTICA RD, Fraser, MI 48026
5862967250
In practice since 2005 (20 years)
NPI: 1437144482 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Valice from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valice? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Valice

Dr. James Valice is an ophthalmology specialist in Fraser, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Valice performed 8,931 Medicare services across 3,544 unique beneficiaries.

Between the years covered by Open Payments, Dr. Valice received a total of $2,340 from 20 pharmaceutical and/or device companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Valice is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 8% volume in MI $2,340 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,931
Medicare services
Top 8% in MI for ophthalmology
3,544
Unique beneficiaries
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~447 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,407 $29 $113
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,395 $91 $320
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,265 $88 $165
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,088 $95 $144
Aflibercept eye injection (Eylea) 1,030 $690 $1,018
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
847 $68 $105
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
229 $158 $223
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
173 $54 $174
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
163 $27 $70
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
84 $104 $238
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
80 $69 $100
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
49 $90 $193
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
47 $70 $115
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
28 $915 $2,648
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
24 $116 $204
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
22 $703 $1,586
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,340
Total received (2018-2024)
Avg $334/year across 7 years
Top 31% in MI for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
89
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,340 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$601
2023
$415
2022
$396
2021
$246
2020
$152
2019
$258
2018
$273

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$198
Genentech USA, Inc.
$108
Apellis Pharmaceuticals, Inc.
$105
ABBVIE INC.
$83
Amgen Inc.
$48
Astellas Pharma US Inc
$21
Johnson & Johnson Surgical Vision, Inc.
$21
Oyster Point Pharma, Inc.
$17
Top 3 companies account for 68.4% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$712
Novartis Pharmaceuticals Corporation
$254
OPTOS, INC.
$214
Apellis Pharmaceuticals, Inc.
$197
Genentech USA, Inc.
$164
ABBVIE INC.
$143
Allergan, Inc.
$136
AbbVie Inc.
$103
Bausch & Lomb, a division of Bausch Health US, LLC
$72
Bausch & Lomb Americas Inc.
$70
Alcon Vision LLC
$56
Amgen Inc.
$48
Lombart Brothers, Inc.
$31
Biogen, Inc.
$24
Spark Therapeutics, Inc.
$22
Astellas Pharma US Inc
$21
Johnson & Johnson Surgical Vision, Inc.
$21
Carl Zeiss Meditec USA, Inc.
$19
EyePoint Pharmaceuticals US, Inc.
$17
Oyster Point Pharma, Inc.
$17
Top 3 companies account for 50.4% of all-time payments
Associated products mentioned in payments ›
BEOVU · BESIVANCE · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Izervay · LOTEMAX SM · LUMERA · LUXTURNA · MIEBO · Monaco · OPD-III · OZURDEX · PanOptix · RESTASIS MULTIDOSE · Rocklatan · Simbrinza · Syfovre · TEPEZZA · TYRVAYA · Tecnis IOL · VABYSMO · Vabysmo · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Fraser?
Compare ophthalmologists in the Fraser area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
318
Per 100K population
36.2
County median income
$76,399
Nearest hospital
Henry Ford Health Warren Hospital
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Valice is a mixed practice specialist, with above-average Medicare volume (top 8% in MI), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Valice experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Valice performed 2,407 retinal imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Valice receive payments from pharmaceutical companies?
Yes. Dr. Valice received a total of $2,340 from 20 companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valice's costs compare to other ophthalmologists in Fraser?
Dr. Valice's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valice) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →